This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
Earlier this year Congress extended CMS’s hospital-at-home waiver for five years via the Consolidated Appropriations Act of 2026. With that bold stroke, ‘HaH’ services became eligible for Medicare reimbursement through September of 2030.
Using a DCB that releases sirolimus over an extended period of time appears to be both safe and effective when treating patients who present with NSTEMI or unstable angina.
As this midterm-election year barrels toward decision day, health insurers continue taking punches from both political parties. The piling-on might be as unfair as it is understandable.
Boarding is hospital-speak for when patients get left in the emergency department, typically on gurneys or in wheelchairs, for many hours—sometimes days—because no inpatient beds are available.
The EARLY TAVR clinical trial made a significant impact, paving the way for the FDA to approve multiple transcatheter heart valves for the treatment of asymptomatic patients. However, one cardiologist who participated in the trial has some serious concerns with how its findings were presented to the public.
The Joint Commission is partnering with the Coalition for Health AI to scale AI accountability. The project will supply more than 80% of U.S. provider orgs with gameplans, toolkits and overall guidance.
To maximize returns on AI investments, healthcare organizations should align AI initiatives with core competencies. The effort should focus on optimizing experiences for workforces as well as patients.
Overall, 30-day outcomes were not significantly different for hospitals after being acquired by a private equity firm. However, the study’s authors did identify trends that suggest there may be a drop in the quality of care.
On the technical and ethical planes, the National Academy of Medicine’s fresh guidance may represent the best way yet to ensure alignment of healthcare AI stakeholders.
The shoulders on which healthcare AI stands span from the advent of the World Wide Web, email and electronic medical records to the ubiquity of smartphones, patient portals, telehealth and personal health wearables.
Widaplik, the new polypill from George Medicines, includes telmisartan, amlodipine and indapamide. The FDA's decision comes after positive data were published in both JACC and The Lancet.